Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(48 sites)
United States
Community Cancer Institute, Clovis, California USC/Norris Comprehensive Cancer Center, Los Angeles, California Hoag Memorial Hospital Presbyterian, Newport Beach, California University of Iowa, Iowa City, Iowa John Theurer Cancer Center, Hackensack, New Jersey